| 注册
首页|期刊导航|世界中医药|养正消积胶囊联合肝动脉化疗栓塞治疗对原发性肝癌患者肝功能改善的疗效观察

养正消积胶囊联合肝动脉化疗栓塞治疗对原发性肝癌患者肝功能改善的疗效观察

宋旦哥 谭萍 史华

世界中医药Issue(8):973-975,3.
世界中医药Issue(8):973-975,3.DOI:10.3969/j.issn.1673-7202.2013.08.042

养正消积胶囊联合肝动脉化疗栓塞治疗对原发性肝癌患者肝功能改善的疗效观察

Efficacy Observation of Yangzhengxiaoji Capsule Combined with Hepatic Artery Chemotherapy Embolism in Improving Liver Function in Patients with Primary Hepayic Carcinoma

宋旦哥 1谭萍 2史华2

作者信息

  • 1. 杭州市第七人民医院肿瘤科,杭州,310013
  • 2. 浙江省肿瘤医院,杭州,310022
  • 折叠

摘要

Abstract

Objective:To observe regulating effect of yangzhengxiaoji capsule on primary hepayic carcinoma patients treated by interven -tional hepatic artery perfusion embolism .Methods: A total of 457 patients were randomly divided into two groups .Treatment group:232 cases of oral yangzhengxiaoji capsule , (four pieces at a time, three times a day, taken orally with warm water 30 min after meal) +hepatic artery chemotherapy embolism;control group:225 cases that use hepatic artery chemotherapy embolism only .Medicine of both groups was DDP+ADM and the course lasted four weeks.Results:Treatment group and control group had no significant differences in treatment efficiency (P>0.05).The index before and after experiment in each group showed significant changes , and is of statistical significance (P<0.05).Compared with control group, all liver function indicator in the treatment group , except for PT, all showed sig-nificant differences(P<0.05).Treatment group showed no obvious adverse reactions compared with control group .Conclusion:Yang-zhengxiaoji capsule with hepatic artery chemotherapy embolism is effective in improving liver function in patients with primary hepayic carcinoma.No obvious adverse reactions have been found thus is suitable for clinical application .

关键词

养正消积胶囊/原发性肝癌/肝功能

Key words

Yangzhengxiaoji Capsule/Primary Hepayic Carcinoma/Liver function

引用本文复制引用

宋旦哥,谭萍,史华..养正消积胶囊联合肝动脉化疗栓塞治疗对原发性肝癌患者肝功能改善的疗效观察[J].世界中医药,2013,(8):973-975,3.

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文